Vinay Prasad Returns to FDA After Being Ousted
By I. Edwards HealthDay Reporter
MONDAY, Aug. 11, 2025 — The U.S. Food and Drug Administration (FDA)’s top vaccine regulator is returning to his post less than two weeks after the White House had him ousted.
Dr. Vinay Prasad will again head the FDA’s Center for Biologics Evaluation and Research, which oversees vaccines and complex treatments for serious diseases, the U.S. Department of Health and Human Services (HHS) confirmed.
HHS spokesperson Andrew Nixon said Prasad is resuming his role "at the FDA’s request," according to The Washington Post.
"Neither the White House nor HHS will allow the fake news media to distract from the critical work the FDA is carrying out under the Trump administration," Nixon added in a statement.
Prasad, a hematologist-oncologist, joined the Trump administration as a senior health official after publicly criticizing the government’s response to the COVID-19 pandemic.
On July 29, he was removed from his role after some conservative figures such as far-right activist and conspiracy theorist Laura Loomer criticized his approach to drug approvals and his past political views.
However, a White House review found the complaints to be disingenuous, according to two people familiar with the situation.
White House spokesperson Kush Desai said it was "not only appropriate, but critical for the Administration to recruit the most qualified and experienced staffers who are totally aligned with President Trump’s agenda to 'Make America Great Again'."
The reversal followed FDA Commissioner Dr. Marty Makary advocating for Prasad’s return.
“The idea that he was pushed out by anybody is simply untrue,” Makary said at a news conference. “He saw some media headlines and didn’t want to be a distraction. We have encouraged him to reconsider, and we’re still doing that.”
In a post on X, Loomer criticized the decision, calling it an “egregious personnel decision,” and vowed to increase her investigations into HHS and FDA officials.
It is unclear whether Prasad will also return to his additional former role as the FDA’s chief medical and scientific officer.
Sources
- The Washington Post, Aug. 10, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Boar's Head Plant to Reopen After Deadly Listeria Outbreak, but Concerns Remain
MONDAY, Aug. 11, 2025 — A Boar’s Head deli meat plant in Virginia that was linked to a deadly listeria outbreak last year will reopen soon, federal officials say. But...
How Confidence and Positivity May Ease Fear of Childbirth
MONDAY, Aug. 11, 2025 — Up to 60% of women feel some level of fear about giving birth, but a new study suggests that a strong sense of mental well-being could make a...
Stalking Victims At Higher Risk For Future Heart Problems
MONDAY, Aug. 11, 2025 — Victims of stalkers appear to have an increased risk of heart disease, a new study says. Women who had been stalked or had obtained a restraining...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.